ACE releases latest trance of drug guidances (April 2022)

1 April 2022 - The Agency for Clinical Effectiveness has released another batch of drug guidances. ...

Read more →

Updated procedures and guidelines for company submissions to ACE

25 March 2022 - Version 1.1 of ACE's "Procedures and guidelines for company submissions to the Agency for Care Effectiveness for ...

Read more →

Antengene announces Xpovio regulatory approval in Singapore for the treatment of relapsed and/or refractory multiple myeloma and relapsed/refractory diffuse large B-cell lymphoma in three indications

1 March 2022 - First and only in a unique class of XPO1 inhibitors to be approved in Singapore. ...

Read more →

Singapore is the latest country to approve Novavax’s COVID vaccine while the U.S. reviews application

14 February 2022 - On Monday, Singapore approved the COVID vaccine from U.S. vaccine maker Novavax for adults over age 18, ...

Read more →

Everest Medicines announces first drug approval of Trodelvy in Singapore for second-line metastatic triple negative breast cancer

6 February 2022 - Singapore Health Sciences Authority approval marks the first in a series of expected approvals of Trodelvy ...

Read more →

Singapore's health care system: key features, challenges, and shifts

2 September 2021 - Since Singapore became an independent nation in 1965, the development of its health care system has been ...

Read more →

Singapore approves Moderna's COVID-19 vaccine: side effects of jab similar to Pfizer's

3 February 2021 - Side effects for the newly approved Moderna COVID-19 vaccine are similar to those reported about the ...

Read more →

Singapore's Agency for Care Effectiveness publishes another tranche of drug guidances

1 September 2020 - Plain English summaries are also available. ...

Read more →

Towards greater impact in health technology assessment: horizon scanning for new and emerging technologies in Singapore

22 June 2020 - To alert policy makers early about emerging health technologies that could significantly impact the healthcare system at ...

Read more →

Superb health care at ultra low prices? How Singapore does it

26 May 2020 - Can you imagine the United States having a health care system that delivers better outcomes than those ...

Read more →

Health technology assessment and its use in drug policies: Singapore

2 December 2019 - Singapore has a robust health care system that is well known for delivering good health outcomes.  ...

Read more →

Puma Biotechnology licensing partner Specialised Therapeutics receives marketing approval in Singapore for Nerlynx (neratinib) for extended adjuvant treatment of early stage hormone receptor positive HER2-positive breast cancer

2 December 2019 - Puma Biotechnology announced that its licensing partner Specialised Therapeutics Asia has received marketing approval of Nerlynx (neratinib) ...

Read more →

FDA’s Project Orbis may expand to Singapore and Switzerland

12 November 2019 - The US FDA may expand a pilot project that allows for simultaneous drug approval decisions from ...

Read more →

Rare Disease Fund now covers Pompe disease, a rare inherited neuromuscular disorder

3 November 2019 - The Rare Disease Fund now covers Singaporeans with Pompe disease - a rare inherited neuromuscular disorder ...

Read more →

New hope for patients with rare diseases with the launching of a new fund

2 July 2019 - Singaporeans with three forms of rare diseases now have access to financial aid to help with ...

Read more →